AFORÉ™ BY DR. FEW ANNOUNCES PUBLICATION OF THE FIRST-EVER STUDY EVALUATING THE EFFECTS OF RETINOL AND CANNABIDIOL (CBD) IN TOPICAL SKINCARE
/PRNewswire/ -- Aforé™ by Dr. Few, a clinically developed skincare line built around Dr. Julius Few's innovative Four Dimensional Beauty™ philosophy, today...
Source: prnewswire.com